Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Ancillary studies in cytology: Secondary or necessary?

Clark DP.

Cancer Cytopathol. 2018 Aug;126 Suppl 8:584-589. doi: 10.1002/cncy.22011. Review.

PMID:
30156778
2.

Biomarkers for immune checkpoint inhibitors: The importance of tumor topography and the challenges to cytopathology.

Clark DP.

Cancer Cytopathol. 2018 Jan;126(1):11-19. doi: 10.1002/cncy.21951. Epub 2017 Nov 13. Review.

3.

Trametinib with and without pazopanib has potent preclinical activity in thyroid cancer.

Ball DW, Jin N, Xue P, Bhan S, Ahmed SR, Rosen DM, Schayowitz A, Clark DP, Nelkin BD.

Oncol Rep. 2015 Nov;34(5):2319-24. doi: 10.3892/or.2015.4225. Epub 2015 Aug 26.

4.

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.

Xing M, Alzahrani AS, Carson KA, Viola D, Elisei R, Bendlova B, Yip L, Mian C, Vianello F, Tuttle RM, Robenshtok E, Fagin JA, Puxeddu E, Fugazzola L, Czarniecka A, Jarzab B, O'Neill CJ, Sywak MS, Lam AK, Riesco-Eizaguirre G, Santisteban P, Nakayama H, Tufano RP, Pai SI, Zeiger MA, Westra WH, Clark DP, Clifton-Bligh R, Sidransky D, Ladenson PW, Sykorova V.

JAMA. 2013 Apr 10;309(14):1493-501. doi: 10.1001/jama.2013.3190.

5.

Functional profiling of live melanoma samples using a novel automated platform.

Schayowitz A, Bertenshaw G, Jeffries E, Schatz T, Cotton J, Villanueva J, Herlyn M, Krepler C, Vultur A, Xu W, Yu GH, Schuchter L, Clark DP.

PLoS One. 2012;7(12):e52760. doi: 10.1371/journal.pone.0052760. Epub 2012 Dec 28.

6.

Practice patterns in cervical cancer screening and human papillomavirus testing.

Tatsas AD, Phelan DF, Gravitt PE, Boitnott JK, Clark DP.

Am J Clin Pathol. 2012 Aug;138(2):223-9. doi: 10.1309/AJCPPVX91HQMNYZZ.

PMID:
22904133
7.

Three-gene molecular diagnostic model for thyroid cancer.

Prasad NB, Kowalski J, Tsai HL, Talbot K, Somervell H, Kouniavsky G, Wang Y, Dackiw AP, Westra WH, Clark DP, Libutti SK, Umbricht CB, Zeiger MA.

Thyroid. 2012 Mar;22(3):275-84. doi: 10.1089/thy.2011.0169. Epub 2012 Jan 26.

8.

Spectrum of risk of malignancy in subcategories of 'atypia of undetermined significance'.

Olson MT, Clark DP, Erozan YS, Ali SZ.

Acta Cytol. 2011;55(6):518-25. doi: 10.1159/000333232. Epub 2011 Dec 9.

PMID:
22156460
9.

Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration.

Yung RC, Otell S, Illei P, Clark DP, Feller-Kopman D, Yarmus L, Askin F, Gabrielson E, Li QK.

Cancer Cytopathol. 2012 Jun 25;120(3):185-95. doi: 10.1002/cncy.20199. Epub 2011 Dec 5.

10.

Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.

Fakhry C, Rosenthal BT, Clark DP, Gillison ML.

Cancer Prev Res (Phila). 2011 Sep;4(9):1378-84. doi: 10.1158/1940-6207.CAPR-11-0284. Epub 2011 Aug 11.

11.

Biospecimen Reporting for Improved Study Quality.

Moore HM, Kelly A, Jewell SD, McShane LM, Clark DP, Greenspan R, Hainaut P, Hayes DF, Kim P, Mansfield E, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J.

Biopreserv Biobank. 2011 Apr;9(1):57-70.

12.

Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory.

Phelan DF, Boitnott JK, Clark DP, Dubay LC, Gravitt PE.

Obstet Gynecol. 2011 Aug;118(2 Pt 1):289-95. doi: 10.1097/AOG.0b013e3182253c33.

13.

Biospecimen reporting for improved study quality (BRISQ).

Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield E, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J.

J Proteome Res. 2011 Aug 5;10(8):3429-38. doi: 10.1021/pr200021n. Epub 2011 Jun 21.

14.

Biospecimen reporting for improved study quality (BRISQ).

Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, Hayes DF, Hainaut P, Kim P, Mansfield EA, Potapova O, Riegman P, Rubinstein Y, Seijo E, Somiari S, Watson P, Weier HU, Zhu C, Vaught J.

Cancer Cytopathol. 2011 Apr 25;119(2):92-101. doi: 10.1002/cncy.20147. Epub 2011 Mar 22.

15.

The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.

Stoll LM, Johnson MW, Gabrielson E, Askin F, Clark DP, Li QK.

Cancer Cytopathol. 2010 Dec 25;118(6):441-9. doi: 10.1002/cncy.20108. Epub 2010 Sep 9.

16.

Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration.

Stoll LM, Yung RC, Clark DP, Li QK.

Cancer Cytopathol. 2010 Oct 25;118(5):278-86. doi: 10.1002/cncy.20103.

17.

NKX3.1 as a marker of prostatic origin in metastatic tumors.

Gurel B, Ali TZ, Montgomery EA, Begum S, Hicks J, Goggins M, Eberhart CG, Clark DP, Bieberich CJ, Epstein JI, De Marzo AM.

Am J Surg Pathol. 2010 Aug;34(8):1097-105. doi: 10.1097/PAS.0b013e3181e6cbf3.

18.

Analysis of nondiagnostic results after image-guided needle biopsies of musculoskeletal lesions.

Yang J, Frassica FJ, Fayad L, Clark DP, Weber KL.

Clin Orthop Relat Res. 2010 Nov;468(11):3103-11. doi: 10.1007/s11999-010-1337-1. Epub 2010 Apr 10.

19.

Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology.

Savic S, Franco N, Grilli B, Barascud Ade V, Herzog M, Bode B, Loosli H, Spieler P, Schönegg R, Zlobec I, Clark DP, Herman JG, Bubendorf L.

Chest. 2010 Jul;138(1):137-44. doi: 10.1378/chest.09-1951. Epub 2010 Feb 5.

PMID:
20139227
20.

Molecular diagnostics on thyroid fine-needle aspirations: the pathway to value creation.

Clark DP.

Cancer Cytopathol. 2010 Feb 25;118(1):14-6. doi: 10.1002/cncy.20064. No abstract available.

Supplemental Content

Loading ...
Support Center